SciELO - Scientific Electronic Library Online

 
vol.34 número3Una reflexión sobre los resultados de la ENSANUT 2022 sobre hipertensión arterial en adultos mexicanos índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


Cardiovascular and metabolic science

versão On-line ISSN 2954-3835versão impressa ISSN 2683-2828

Cardiovasc. metab. sci vol.34 no.3 Ciudad de México Jul./Set. 2023  Epub 15-Abr-2024

https://doi.org/10.35366/112756 

Editorial

Cardiac risk of transgender, let us take it seriously

Riesgo cardiaco de los transexuales, tomémoslo en serio

Rafael Moguel-Ancheita1  * 

Beatriz Moguel-Ancheyta2 

1 The Clinics of the Heart/Costamed. Colegio Mexicano de Cardiología Intervencionista (COMECITE). Mexico.

2 Consejo de la Judicatura Federal. Mexico.


The cardiovascular community must face human rights regarding gender identity that demands specific knowledge and skills for cardiac disease prevention, diagnosis, and multidisciplinary interaction.

We are not discussing genetic and phenotypic sexual determination at birth, but the personal perception of a non-originally assigned gender, called transgender, in which someone seeks for medical interventions to alter the body to change from the born gender through the self-perceived one, on two conditions:

  • Transgender men, transmen, female-to-men, or FTM. The born women switch or want to change to men.

  • Transgender women, transwomen, male-to-female, or MTF. The born men switch or want to change to women.1

To anticipate how often a person will need professional attention, let us look at the Mexican national statistics, considering that these concepts are relatively new and may exclude older people who feel uncomfortable declaring their gender identity. The National Institute of Statistics and Geography (INEGI from Instituto Nacional de Estadística y Geografía) estimates 0.9% transgender from the Mexican population that may seek medical services in all public institutes and private practice.2 This information brought a recently published Mexican cardiology opinion.3

The current evidence points towards a myocardial infarction risk increase of over two-fold in FTM compared to cisgender men and four-fold compared to cisgender women. Contrarily, MTF has over two-fold risk against cisgender women, suggesting FTM receives a significant risk impact.4 This problem was mentioned in the Mexican Consensus on Chronic Ischemic Heart Disease. Non-invasive diagnosis, classification, and stratification. Mexican College of Interventional Cardiology and Endovascular Therapy (COMECITE).5

Hormonal basics in cisgenders indicate a progressive increase in cardiovascular risk in men. In contrast, there is a rapid rise in women after menopause, especially in early menopause, either natural or surgical.6 The gender-affirming hormone therapy may be responsible for the risk mentioned above but also associates to double the risk for ischemic stroke on MTF against cisgender men, especially in prolonged hormonal therapy for more than six years. On prolonged oral hormone therapy, the same group has 20 to 40 times the risk for thromboembolic complications.7,8

Different publications render conflicting results regarding cardiovascular risk factors. Nonetheless, transgender people may have more incidence of smoking, increased body weight, alcohol and other substance abuse, sedentarism, inadequate nutrition (more fast-food preference), dyslipidemia, and especially HIV infection. The relationship between these risk factors and cardiac events is unclear, except for HIV infection, which unequivocally gives evident high risk.9

Minority stress deserves particular attention, yet being transgender is not easy but quite difficult and stressful due to the self-perception of rejection caused by transphobia, which leads to physical and psychological violence and isolation from society. The latter may be the more significant problem that this population face, provoking a higher tendency towards discrimination, depression, addictions, suicidal ideas and acts, poverty, margination from professional, family, and recreative activities, underemployment, self-medication and possible involvement in illegal activities.10-12

Finally, the more interesting issue concerns transgender people’s medical service, which is unequal, delayed, less efficient, and not inclusive due to fear of mistreatment from the subjects and rejection from clinical staff, including physicians and other patients. This phenomenon creates a vicious circle that perpetuates and aggravates mental and physical morbidities.13

Concerning the so-called conscientious objection of medical and health personnel, recognized and protected by the Political Constitution of the United Mexican States, The Supreme Court warned (unconstitutionality action 54/2018) of the superlative risk that the absolute and unlimited exercise of this right could entail, especially against the sexual and reproductive rights of women and people of sexual and gender diversity, from the problematic situation in which they find themselves and their historical discrimination. It states that the objection must be compatible and not sacrifice the rights of the beneficiaries of health services. Consequently, the Supreme Court invalidated the article of the General Health Law that authorized the conscientious objection of medical and nursing personnel. That means that, as of today, Mexican law does not protect conscientious objection and that denying health service for reasons of conscience could lead to administrative, civil, or even criminal liability. Besides, refusing health services to sexually/gender diverse people puts their lives at risk by not addressing their high health risks.14

Based on these concepts, our professional community should have a substantial change in transgender care, as follows:

  • Transgender is real, not fiction.

  • Transgender people need and seek medical attention for mental and physical morbidities.

  • They do not need our opinion regarding sexual genetic considerations.

  • Medical care must be inclusive and egalitarian.

  • Cardiologists should interact in the prevention of cardiovascular deterioration.

  • Mexican law does not currently protect conscientious objection.

  • This historical moment is a time for adaptation and interdisciplinary construction to improve transgender people’s smooth and easy life.

  • We want to acknowledge the contribution of Sanya Plata Moguel, Helena Moguel Samaniego, and Virginia Samaniego Méndez.

References

1. American Psychological Association. Understanding transgender people, gender identity and gender expression. 2023. AVAilable in: https://www.apa.org/topics/lgbtq/transgender-people-gender-identity-gender-expressionLinks ]

2. Instituto Nacional de Estadística y Geografía. Comunicado de prensa número 340/22. Encuesta nacional sobre diversidad sexual y de género (ENDISEG) 2021. 2022. Disponible en: https://www.inegi.org.mx/contenidos/saladeprensa/boletines/2022/endiseg/Resul_Endiseg21.pdfLinks ]

3. Esquina 32. Comunidad transgénero es cinco veces más propensa a un infarto al miocardio. Tijuana BC: 2022. Disponible en: https://esquina32.info/2022/09/comunidad-transgenero-es-cinco-veces-mas-propensa-a-un-infarto-al-miocardio/Links ]

4. Alzahrani T, Nguyen T, Ryan A, Dwairy A, McCaffrey J, Yunus R et al. Cardiovascular disease risk factors and myocardial infarction in the transgender population. Circ Cardiovasc Qual Outcomes. 2019; 12 (4): e005597. [ Links ]

5. Moguel-Ancheita R, Arce-Piña L, Lozoya-Morales JJ, Ramos-Cházaro E, Cuevas-Cueto D, Lozoya-del-Rosal JJ et al. Mexican Consensus of Chronic Ischemic Heart Disease. Non-invasive diagnosis, classification, and stratification. Mexican College of Interventional Cardiology and Endovascular Therapy (COMECITE). Cardiovasc Metab Sci. 2021; 32 (s4): s288-s316. [ Links ]

6. Muka T, Oliver-Williams C, Kunutsor S, Laven JS, Fauser BC, Chowdhury R et al. Association of age at onset of menopause and time since onset of menopause with cardiovascular outcomes, intermediate vascular traits, and all-cause mortality: a systematic review and meta-analysis. JAMA Cardiol. 2016; 1 (7): 767-776. [ Links ]

7. Chan Swe N, Ahmed S, Eid M, Poretsky L, Gianos E, Cusano NE. The effects of gender-affirming hormone therapy on cardiovascular and skeletal health: A literature review. Metabol Open. 2022; 13: 100173. [ Links ]

8. Ramsay A, Safer JD. Update in adult transgender medicine. Annu Rev Med. 2023; 74: 117-124. doi: 10.1146/annurev-med-020222-121106. [ Links ]

9. Streed CG Jr, Beach LB, Caceres BA, Dowshen NL, Moreau KL, Mukherjee M et al. Assessing and Addressing Cardiovascular Health in People Who Are Transgender and Gender Diverse: A Scientific Statement From the American Heart Association. Circulation. 2021; 144 (6): e136-e148. Erratum in: Circulation. 2021; 144 (6): e150. [ Links ]

10. Abeyratne D, Ratnayake GM, Wijetnga UA, Wijenayake U, BUlugahapitiya US. Review on the transgender literature: where are we now and a step beyond the current practice? Endocrines. 2022; 3 (2): 317-328. [ Links ]

11. Seal LJ. Cardiovascular disease in transgendered people: A review of the literature and discussion of risk. JRSM Cardiovasc Dis. 2019; 8: 2048004019880745. [ Links ]

12. Pellicane MJ, Ciesla JA. Associations between minority stress, depression, and suicidal ideation and attempts in transgender and gender diverse (TGD) individuals: Systematic review and meta-analysis. Clin Psychol Rev. 2022; 91: 102113. doi: 10.1016/j.cpr.2021.102113. [ Links ]

13. Seelman KL, Colón-Diaz MJP, LeCroix RH, Xavier-Brier M, Kattari L. Transgender noninclusive healthcare and delaying care because of fear: connections to general health and mental health among transgender adults. Transgend Health. 2017; 2 (1): 17-28. doi: 10.1089/trgh.2016.0024. [ Links ]

14. Diario Oficial de la Federación. SEGOB. 21/12/2021. Acción de inconstitucionalidad 54/2018. Disponible en: https://dof.gob.mx/nota_detalle.php?codigo=5638915&fecha=21/12/2021#gsc.tab=0Links ]

*Corresponding author: Rafael Moguel-Ancheita. E-mail: cathboss@gmail.com

Creative Commons License This is an open-access article distributed under the terms of the Creative Commons Attribution License